ReviewBiomolecules & biomedicine2024

Advances in nanotechnology-enabled drug delivery for combining PARP inhibitors and immunotherapy in advanced ovarian cancer.

Lama Abujamous et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.